Texto completo disponível apenas em PDF.
Referências bilbiográficas
- ASHER, R. Apriority – thoughts on treatment. Lancet 1961, ii: 1403-04. BELL, J. The new genetics in clinical practice. BMJ 1998, 316:618-20.
- BRADLEY, F.; WILES, R.; KINMONTH, A.L.; MANT, D.; GANTLEY, M. Development and evaluation of complex interventions in health services research. BMJ (in press).
- BREWIN, C.; BRADLEY, C. Patient preferences and randomised clinical trials. BMJ 1989, 299: 313-15.
- BURKE, P.; BAIN, J.; ROBINSON, D.; DUNLEAVY, J. Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ 1997, 303: 558-69.
- CHARLTON, B. The scope and nature of epidemiology. J Clin Epid 1996, 49:623-26.
- DEL MAR, C.; GLASZIOU, P.; HAYEM, M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997, 314:1526-29.
- DOWIE, J. Evidence based, cost-effective and preference driven medicine: decision analysis based decision making is the prerequisite. J Health Service Res Policy 1996, 1:104-12.
- FAHEY, T. Applying the results of clinical trials to patients in general practice: perceived problems, strengths, assumptions and challenges for the future. Br J Gen Pract 1998, 48:1173-78.
- FIHN, S.; CALLAHAN, C.; MARTIN, D.; MCDONNEL, M.; HENSKOFF, J.; WHITE, R. Risk and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996, 124:970-79.
- FROOM, J.; CULPEPPER, C.; GROB, P.; BARTELDS, A.; BOWERS, P.; BRIDGES WEBB, C. Diagnosis of antibiotic treatment of acute otitis media. BMJ 1990, 300:582-86.
- GLASZIOU, P. & IRWIG, L. An evidence based approach to individualizing treatment. BMJ 1995, 311: 1356-1359.
- GUYATT, G.; JUNIPER, E.; WALTER, S.; GRIFFITH, L.; GOLDSTEIN, R. Interpreting treatment effects in randomised trials. BMJ 1998, 316:690-93.
- HART, J.T. What evidence do we need for evidence based medicine? J Edip Comm Health 1997, 51: 623-629.
- KERRIDGE, I.; LOWE, M.; HENRY, D. Ethics and evidence based medicine. BMJ 1998, 316: 1151-53.
- LILFORD, R. & JACKSON, J. Equipoise and the ethics of randomisation. J R Soc Med 1995, 88:552-59.
- MCPHERSON, K.; BRITTON, A.; WENNBERG, J. Are randomised controlled trials controlled? Patient preferences and unblind trials. J R Soc Med 1997, 90:652-56.
- NAYLOR, C.D. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995, 345: 840-42.
- O’BOYLE, C. Diseases with passion. Lancet 1993, 342:1126-27.
- OXMAN, A. & GUYATT, G. A consumers’ guide to sub-group analysis. Ann Intern Med 1992; 116:78-84.
- ROTHWELL, P.M. Can results of clinical trials be applied to all patients. Lancet 1995, 345: 1616-19.
- RUCKER, G. A two-stage trial design for testing treatment, self-selection and treatment preference effects. Stats Med 1989, 8:477-85.
- SACKETT, D.; RICHARDSON, W.; ROSENBERG, W.; HAYNES, R.B. Evidence based medicine: how to practice and teach EBM London: Churchill Livingstone, 1996.
- SACKETT, D.; ROSENBERG, W.; GRAY, J.A.M. Evidence based medicine: what it is and what it isn’t. BMJ 1996, 312:71-72.
- SENN, S. Random results from randomised trials. BMJ 1998,317:537.
- SILAGY, C.A. Developing a register of randomised controlled trials in primary care. BMJ 1993, 306: 887-900.
- SULLIVAN, F.M.; MACNAUGHTON, R.J. Evidence in consultations: intrepreted and individualised. Lancet 1996, 348:941-43.
- SWEENEY, K.; GRAY, D.P.; STEELE, R.; EVANS, P. Use of warfarin in non-rheumatic atrial fibrillation. Br J Gen Pract 1995, 45: 153-58.
- SWEENEY, K.G.; MACAULEY, D.; PEREIRA GRAY, D. Personal significance: the third dimension. Lancet 1998, 35: 134-136.
- VAN WEEL, C. Chronic disease in general practice: the longitudinal dimension. Eur J Gen Pract 1996, 2:17-21.
- VAN WEEL, C. Primary care: political favourite or scientific discipline? Lancet 1996, 348: 1431-32.
Datas de Publicação
-
Publicação nesta coleção
Apr-Jun 2001
Histórico
-
Recebido
Jan 2001 -
Aceito
Maio 2001
